详情

       The 66th Annual Meeting of the American Society of Radiological Oncology (ASTRO) was held in Washington, DC, USA from September 29 to October 2, 2024.

       Linatech has been deeply involved in the radiotherapy industry for 30 years, and we have participated in ASTRO every year. On this world stage, we have launched 

many innovative products such as radiation therapy planning System (TPS), electric multi-leaf collimator (MLC), image guidance system (IVS) and so on. VenusX Medical

 linear Accelerator (FDA approved) made a spectacular debut, kicking off global sales. During the exhibition, friends gathered together, experts directions, indicating a 

promising future for Linatech.

       As an important means to treat cancer, the radiotherapy industry market has experienced significant growth in the past few years, and the global market size of medical linear accelerators has reached 25.876 billion yuan in 2023. The market is expected to grow at an annual rate of 7% over the next few years and reach $10 billion by 2025 ‌. VARIAN and ELEKTA have 90% of the global market. Linatech has stepped onto the international stage, competing with leading companies in the industry.

      In the era of globalization, scientific and technological innovation is changing rapidly. We keep up with the pace of The Times, constantly bring new technologies and innovative products to radiotherapy.